diabetes with peripheral arterial occlusive disease相关文献:
[Diabetic foot syndrome-Part 1 : Definition, pathophysiology, diagnostics and classification].
Rümenapf G, Morbach S, Rother U, Uhl C, Görtz H, Böckler D, Behrendt CA, Hochlenert D, Engels G, Sigl M; Kommission PAVK und Diabetisches Fußsyndrom der DGG e. V..
The Charcot foot: pathophysiology, diagnosis and classification.
Trieb K.
Bone Joint J. 2016 Sep;98-B(9):1155-9. doi: 10.1302/0301-620X.98B9.37038.
PMID:27587513
Diabetic foot ulcers: prevention, diagnosis and classification.
Armstrong DG, Lavery LA.
Am Fam Physician. 1998 Mar 15;57(6):1325-32, 1337-8.
PMID:9531915
Antithrombotic Treatment for Peripheral Arterial Occlusive Disease.
Hardung D, Behne A, Boral M, Giesche C, Langhoff R.
Dtsch Arztebl Int. 2021 Aug 9;118(31-32):528-535. doi: 10.3238/arztebl.m2021.0157.
PMID:33734081
Treatment of Peripheral Arterial Occlusive Disease around the Globe: Malta.
Dimech AP, Galea SA, Cassar K, Grima MJ.
J Clin Med. 2021 Dec 8;10(24):5747. doi: 10.3390/jcm10245747.
PMID:34945042
Toward a targeted approach to diabetes-related peripheral arterial occlusive disease.
El Khoury R, Dardik A.
JVS Vasc Sci. 2023 May 9;4:100112. doi: 10.1016/j.jvssci.2023.100112. eCollection 2023.
PMID:37496885
Decrease of peripheral resistance after intraoperative administration of iloprost in patients with and without type 2 diabetes mellitus and with peripheral arterial occlusive disease.
Hirsch K, Säemann M, Walter C, Taher F, Edda S, Mlekusch I, Jäger H, Assadian A, Falkensammer J.